Literature DB >> 31794087

EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management.

Raimund Stein1, Guy Bogaert2, Hasan S Dogan3, Lisette Hoen4, Radim Kocvara5, Rien J M Nijman6, Josine Quaedackers6, Yazan F Rawashdeh7, Mesrur S Silay8, Serdar Tekgul3, Christian Radmayr9.   

Abstract

BACKGROUND: Treatment in children and adolescents with a neurogenic bladder is primarily conservative with the goal of preserving the upper urinary tract combined with a good reservoir function of the bladder. However, sometimes-even in childhood-conservative management does not prevent the development of a low-compliant bladder or overactive detrusor. MATERIAL &
METHODS: After a systematic literature review covering the period 2000-2017, the ESPU/EUAU guideline for neurogenic bladder underwent an update.
RESULTS: In these patients, surgical interventions such as botulinum toxin A injections into the detrusor muscle, bladder augmentation, and even urinary diversion may become necessary to preserve the function of the upper (and lower) urinary tracts. The creation of a continent catheterizable channel should be offered to patients with difficulties performing transurethral clean intermittent catheterization. However, a revision rate of up to 50% needs to be considered. With increasing age continence of urine and stool becomes progressively more important. In patients with persistent weak bladder outlets, complete continence can be achieved only by surgical interventions creating a higher resistance/obstruction at the level of the bladder outlet with a success rate of up to 80%. In some patients, bladder neck closure and the creation of a continent catheterizable stoma is an option.
CONCLUSION: In all these patients close follow-up is mandatory to detect surgical complications and metabolic consequences early.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  EAU guideline; Mitrofanoff stoma; bladder augmentation; bladder neck reconstruction; neurogenic bladder; sling procedure; urinary diversion

Year:  2019        PMID: 31794087     DOI: 10.1002/nau.24248

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  7 in total

1.  Continence management in children with severe caudal regression syndrome: role of multidisciplinary team and long-term follow-up.

Authors:  Giacomo Esposito; Giorgia Totonelli; Barbara Daniela Iacobelli; Daniela Longo; Tamara Caldaro; Giulia Blasetti; Francesca Bevilacqua; Francesca Santato; Giulia Lucignani; Maria Laura Sollini; Carlo Efisio Marras; Pietro Bagolan; Giovanni Mosiello
Journal:  Pediatr Surg Int       Date:  2022-08-09       Impact factor: 2.003

2.  Anorectal malformation, urethral duplication, occult spinal dysraphism (ARM-UD-OSD): a challenging uncommon association.

Authors:  Federica Lena; Chiara Pellegrino; Antonio Maria Zaccara; Maria Luisa Capitanucci; Giacomo Esposito; Barbara Daniela Iacobelli; Daniela Longo; Tamara Caldaro; Diletta Bruno; Francesca Bevilacqua; Francesca Santato; Giulia Lucignani; Carlo Efisio Marras; Enrico Castelli; Pietro Bagolan; Giovanni Mosiello
Journal:  Pediatr Surg Int       Date:  2022-07-26       Impact factor: 2.003

3.  Expression profiles of long non-coding RNAs in neurogenic bladder of spinal cord injured rats: a transcriptomic analysis.

Authors:  Jimeng Ruan; Zhenhua Shang; Hao Yan; Bo Cui; Qi Wang; Jiangtao Wu; Chunsong Jia; Xin Cui; Jin Li; Tongwen Ou
Journal:  Transl Androl Urol       Date:  2022-06

4.  Spheroids of Bladder Smooth Muscle Cells for Bladder Tissue Engineering.

Authors:  Tim Gerwinn; Souzan Salemi; Lisa Krattiger; Daniel Eberli; Maya Horst
Journal:  Biomed Res Int       Date:  2021-11-11       Impact factor: 3.411

5.  Improvement of bladder function after bladder augmentation surgery: a report of 26 years of clinical experience.

Authors:  Katharina C Trojan; Joanna Schneider; Angela M Kaindl; Anja Lingnau; Beatriz Bañuelos Marco; Luise Ciesla; Tamara Geppert
Journal:  Pediatr Surg Int       Date:  2022-03-28       Impact factor: 2.003

6.  Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder.

Authors:  Sanjay Sinha; Mehul Shah
Journal:  Asian J Urol       Date:  2021-06-01

7.  Botulinum toxin A improves neurogenic bladder fibrosis by suppressing transforming growth factor β1 expression in rats.

Authors:  Chunsong Jia; Tianying Xing; Zhenhua Shang; Xin Cui; Qi Wang; Tongwen Ou
Journal:  Transl Androl Urol       Date:  2021-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.